Kehua Biotech announced that the company and its holding subsidiary Suzhou Tianlong Biotechnology Co., Ltd. recently received two medical device registration certificates issued by the State Drug Administration, namely the company's Chlamydia trachomatis nucleic acid detection kit and Suzhou Tianlong's parainfluenza virus nucleic acid detection kit. The registration certificates are valid from September 14, 2026 to September 13, 2031. Obtaining the above registration certificate has enriched the company's product line and will have a positive impact on the company's business development, and it is not yet possible to predict its impact on future revenue.

Kehua Biotech announced that the company and its holding subsidiary Suzhou Tianlong Biotechnology Co., Ltd. recently received two medical device registration certificates issued by the State Drug Administration, namely the company's Chlamydia trachomatis nucleic acid detection kit and Suzhou Tianlong's parainfluenza virus nucleic acid detection kit. The registration certificates are valid from September 14, 2026 to September 13, 2031. Obtaining the above registration certificate has enriched the company's product line and will have a positive impact on the company's business development, and it is not yet possible to predict its impact on future revenue.